Augmenting trabeculectomy in glaucoma with subconjunctival mitomycin C versus subconjunctival 5-fluorouracil: a randomized clinical trial
Ali MostafaeiNikoukari Ophthalmology University Hospital, Tabriz University of Medical Sciences, Tabriz, IranObjective: The aim of this study was to compare the efficacy of augmenting trabeculectomy with subconjunctival mitomycin C (TMMC) versus 5-fluorouracil (T5-FU) in lowering intraocular pressur...
Guardado en:
Autor principal: | Mostafaei A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a949e02b48346b492936aefc5763c05 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed AM, et al.
Publicado: (2014) -
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
por: Sedghipour MR, et al.
Publicado: (2011) -
Postoperative subconjunctival bevacizumab injection as an adjunct to 5-fluorouracil in the management of scarring after trabeculectomy
por: Freiberg FJ, et al.
Publicado: (2013) -
Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
por: Marey HM, et al.
Publicado: (2011) -
Subconjunctival hemorrhage: risk factors and potential indicators
por: Tarlan B, et al.
Publicado: (2013)